Athira Pharma Inc (ATHA)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: ATHA Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-01-03	2025-01-02	S Sale	San Martin Javier CHIEF MEDICAL OFFICER Officer	10,826 -23.2% 0.56 USD 6,083	10,826 -23.2%	0.56	USD 6,083
2025-01-03	2025-01-02	S Sale	Worthington Mark General Counsel and CCO Officer	8,510 -9.2% 0.56 USD 4,782	8,510 -9.2%	0.56	USD 4,782
2025-01-03	2025-01-02	S Sale	Renninger Robert VP of Finance Officer	2,881 -3.1% 0.56 USD 1,619	2,881 -3.1%	0.56	USD 1,619
2025-01-03	2025-01-02	S Sale	Litton Mark James President and CEO Executive Director	25,107 -9.4% 0.56 USD 14,108	25,107 -9.4%	0.56	USD 14,108
2025-01-03	2025-01-02	S Sale	CHURCH KEVIN CHIEF SCIENTIFIC OFFICER Officer	8,510 -6.1% 0.56 USD 4,782	8,510 -6.1%	0.56	USD 4,782
2024-09-05	2024-09-05	S Sale	Lenington Rachel COO and CDO Officer	2,525 -10.8% 0.57 USD 1,429	2,525 -10.8%	0.57	USD 1,429
2024-09-05	2024-09-05	S Sale	Worthington Mark GENERAL COUNSEL Officer	2,525 -4.6% 0.57 USD 1,429	2,525 -4.6%	0.57	USD 1,429
2024-09-05	2024-09-05	S Sale	CHURCH KEVIN CHIEF SCIENTIFIC OFFICER Officer	2,525 -2.7% 0.57 USD 1,429	2,525 -2.7%	0.57	USD 1,429
2024-09-05	2024-09-05	S Sale	Gengos Andrew CFO and Chief Business Officer Officer	1,272 -1.3% 0.57 USD 720	1,272 -1.3%	0.57	USD 720
2024-09-05	2024-09-05	S Sale	Litton Mark James President and CEO Executive Director	5,032 -3.1% 0.57 USD 2,848	5,032 -3.1%	0.57	USD 2,848
2024-06-25	2024-06-24	B Purchase	Romano Kelly A Non-Executive Director	27,400 +51.4% 2.42 USD 66,179	27,400 +51.4%	2.42	USD 66,179
2024-06-25	2024-06-21	B Purchase	Romano Kelly A Non-Executive Director	15,000 +39.1% 2.26 USD 33,872	15,000 +39.1%	2.26	USD 33,872
2024-01-08	2024-01-05	S Sale	Lenington Rachel Chief Operating Officer Officer	2,412 -15.3% 2.91 USD 7,019	2,412 -15.3%	2.91	USD 7,019
2024-01-08	2024-01-05	S Sale	Worthington Mark General Counsel Officer	2,412 -6.5% 2.91 USD 7,019	2,412 -6.5%	2.91	USD 7,019
2024-01-08	2024-01-05	S Sale	Litton Mark James Chief Executive Officer Executive Director	4,820 -3.2% 2.91 USD 14,026	4,820 -3.2%	2.91	USD 14,026
2023-12-29	2023-12-29	B Purchase	PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder	163,954 +3.1% 2.38 USD 390,211	163,954 +3.1%	2.38	USD 390,211
2023-12-29	2023-12-28	B Purchase	PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder	409,598 +8.5% 2.44 USD 999,419	409,598 +8.5%	2.44	USD 999,419
2023-12-29	2023-12-27	B Purchase	PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder	32,134 +0.7% 2.28 USD 73,266	32,134 +0.7%	2.28	USD 73,266
2023-06-09	2023-06-07	B Purchase	Gengos Andrew See Below Officer	11,719 +17.2% 3.44 USD 40,308	11,719 +17.2%	3.44	USD 40,308
2023-06-09	2023-06-07	B Purchase	Gengos Andrew See Below Officer	2,859 +4.4% 3.40 USD 9,721	2,859 +4.4%	3.40	USD 9,721
2023-06-09	2023-06-07	B Purchase	Gengos Andrew See Below Officer	422 +0.6% 3.36 USD 1,417	422 +0.6%	3.36	USD 1,417
2023-06-06	2023-06-05	B Purchase	Gengos Andrew See Below Officer	10,000 +18.2% 3.02 USD 30,154	10,000 +18.2%	3.02	USD 30,154
2023-06-06	2023-06-05	B Purchase	Gengos Andrew See Below Officer	10,000 +22.2% 3.00 USD 29,999	10,000 +22.2%	3.00	USD 29,999
2023-06-06	2023-06-05	B Purchase	Gengos Andrew See Below Officer	10,000 +28.6% 3.00 USD 29,997	10,000 +28.6%	3.00	USD 29,997
2023-06-06	2023-06-05	B Purchase	Gengos Andrew See Below Officer	15,000 +75.0% 3.00 USD 45,000	15,000 +75.0%	3.00	USD 45,000
2023-06-06	2023-06-02	B Purchase	Gengos Andrew See Below Officer	3,418 +20.6% 2.95 USD 10,066	3,418 +20.6%	2.95	USD 10,066
2023-06-06	2023-06-02	B Purchase	Gengos Andrew See Below Officer	6,582 +65.7% 2.86 USD 18,823	6,582 +65.7%	2.86	USD 18,823
2023-06-06	2023-06-02	B Purchase	Gengos Andrew See Below Officer	10,012 +inf% 2.75 USD 27,533	10,012 +inf%	2.75	USD 27,533
2023-03-30	2023-03-29	B Purchase	JOHNSON JAMES A Non-Executive Director	5,000 +inf% 2.40 USD 12,000	5,000 +inf%	2.40	USD 12,000
2024-01-08	2023-01-05	S Sale	Gengos Andrew See Below Officer	1,208 -1.4% 2.91 USD 3,515	1,208 -1.4%	2.91	USD 3,515
2024-01-08	2023-01-05	S Sale	CHURCH KEVIN Chief Scientific Officer Officer	2,412 -2.9% 2.91 USD 7,019	2,412 -2.9%	2.91	USD 7,019
2022-12-30	2022-12-28	B Purchase	MILESON GLENNA Chief Financial Officer Officer	50,000 +45.5% 2.85 USD 142,250	50,000 +45.5%	2.85	USD 142,250
2022-12-06	2022-12-02	B Purchase	Romano Kelly A Non-Executive Director	30,000 +360.8% 3.29 USD 98,700	30,000 +360.8%	3.29	USD 98,700
2022-11-17	2022-11-15	B Purchase	MOEBIUS HANS Chief Medical Officer Officer	5,000 +8.2% 3.29 USD 16,442	5,000 +8.2%	3.29	USD 16,442
2022-07-01	2022-06-30	B Purchase	PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder	1,101,362 +29.8% 2.99 USD 3,293,072	1,101,362 +29.8%	2.99	USD 3,293,072
2022-07-01	2022-06-29	B Purchase	PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder	270,000 +7.9% 2.99 USD 807,300	270,000 +7.9%	2.99	USD 807,300
2022-06-24	2022-06-23	S Sale	Worthington Mark General Counsel Officer	2,614 -12.0% 2.69 USD 7,032	2,614 -12.0%	2.69	USD 7,032
2022-06-24	2022-06-23	S Sale	Lenington Rachel Chief Operating Officer Officer	4,193 -41.9% 2.69 USD 11,279	4,193 -41.9%	2.69	USD 11,279
2022-06-24	2022-06-23	S Sale	Litton Mark James Chief Executive Officer Executive Director	7,960 -5.8% 2.69 USD 21,412	7,960 -5.8%	2.69	USD 21,412
2022-06-24	2022-06-23	S Sale	MILESON GLENNA Chief Financial Officer Officer	2,614 -2.3% 2.69 USD 7,032	2,614 -2.3%	2.69	USD 7,032
2022-06-24	2022-06-23	S Sale	CHURCH KEVIN Executive VP, Research Officer	2,614 -4.3% 2.69 USD 7,032	2,614 -4.3%	2.69	USD 7,032
2022-04-01	2022-03-31	B Purchase	Romano Kelly A Non-Executive Director	8,000 +2539.7% 13.11 USD 104,880	8,000 +2539.7%	13.11	USD 104,880
2021-01-27	2021-01-25	B Purchase	PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder	311,111 +10.0% 22.50 USD 6,999,998	311,111 +10.0%	22.50	USD 6,999,998
2020-09-22	2020-09-22	B Purchase	EDELMAN JOSEPH Non-Executive Director Large shareholder	1,058,824 +51.5% 17.00 USD 18,000,008	1,058,824 +51.5%	17.00	USD 18,000,008
2020-09-22	2020-09-22	B Purchase	PERCEPTIVE ADVISORS LLC Large shareholder	1,058,824 +51.5% 17.00 USD 18,000,008	1,058,824 +51.5%	17.00	USD 18,000,008
2020-09-22	2020-09-18	B Purchase	RTW INVESTMENTS, LP Large shareholder	750,000 +39.1% 17.00 USD 12,750,000	750,000 +39.1%	17.00	USD 12,750,000

Athira Pharma Inc (ATHA)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by